Vieworks (100120) Fundamentals 2026 — P/E 7.1x, Revenue Analysis | SniperIQ
Vieworks (100120) is a KR-listed Healthcare company in Medical - Devices with a market capitalization of ₩196.0B, trading at ₩22650.00 on the KOE. This SniperIQ fundamentals page covers Vieworks's valuation (P/E 7.1x, P/B 0.8x), profitability (net margin 12.0%), revenue (₩239.3B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Vieworks's market cap?
Vieworks (100120) has a market capitalization of approximately ₩196.0B, trading at ₩22650.00 on the KOE. Market cap moves with the live share price.
What is Vieworks's P/E ratio?
Vieworks's trailing twelve-month P/E ratio is 7.1x, with a price-to-book (P/B) of 0.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Vieworks?
Vieworks runs a net profit margin of 12.0%, a gross margin of 42.7%, and an operating margin of 11.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Vieworks generate?
Vieworks reported revenue of ₩239.3B for fiscal year 2025, with net income of ₩22.0B and earnings per share (EPS) of 2433.75. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Vieworks pay a dividend?
Vieworks offers a trailing dividend yield of about 2.6%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Vieworks financially healthy?
Vieworks carries a debt-to-equity ratio of 0.29x and a current ratio of 1.86x, with a market beta of 0.39. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Vieworks a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Vieworks (100120) the key facts are: market cap ₩196.0B, P/E 7.1x, revenue ₩239.3B, 52-week range 18010-34900. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Vieworks's full fundamentals live
Get Vieworks's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.